CI
CBPO

Cavalier Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Cavalier Investments’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,200
Closed -$598K – 142
2015
Q4 		$598K Buy
+4,200
New +$485K 0.36% 54

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cavalier Investments's CBPO Position: Q1 2016 in Review

Cavalier Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2016, closing a stake of 4,200 shares — an estimated $598K sold.

Cavalier Investments first reported a position in CBPO in Q4 2015 and held it in 1 quarter. The position peaked at $598K in Q4 2015. 131 funds tracked by Wall St. Rank hold CBPO as of Q1 2016.

  • Cavalier Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
  • Cavalier Investments sold 4,200 China Biologic Products Holdings, Inc. shares in Q1 2016, an estimated $598K.
  • Cavalier Investments first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 1 quarter.
  • Cavalier Investments's China Biologic Products Holdings, Inc. position peaked at $598K in Q4 2015.
  • 131 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2016.

Based on Cavalier Investments's 13F filing for Q1 2016, filed 13 May 2016.